I found two major mistakes.
For example, the original version said that BIA-ALCL was linked only to textured implants. I had to tell them that was not the case, and that textured expanders were also involved, not just the implants themselves. I had to explain to them that in their very minimal blog, they should also warn patients who had undergone breast reconstruction surgery.
I can't remember the other mistake, because it was two years ago, after all.
Is the information at the Health Canada website adequate? No.
Information at the website of the Food and Drug Administration, the FDA, is also probably inadequate. In fact both sites are equally short of information.
An enormous amount of work and effort is needed at health Canada. For the precautionary principle, right now, given that the two studies by Allergan and Mentor…